Skip to main content
Fig. 1 | Trials

Fig. 1

From: Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial

Fig. 1

Trial visits. Abbreviations: incl./excl. criteria, including/excluding criteria; 2h-OGTT, 2-h oral glucose tolerance test; DXA, dual-energy X-ray absorptiometry; fMRI, functional magnetic resonance imaging; Sema 0.25mg/w, semaglutide 0.25 mg per week; Sema 0.5mg/w, semaglutide 0.5 mg per week; Sema 1mg/w, semaglutide 1 mg per week

Back to article page

Trials

ISSN: 1745-6215